Human Gene Module / Chromosome 20 / ADNP

ADNPActivity-dependent neuroprotector homeobox

Score
1
High Confidence Criteria 1.1
Autism Reports / Total Reports
25 / 42
Rare Variants / Common Variants
75 / 0
Aliases
ADNP, ADNP1
Associated Syndromes
Helsmoortel-Van der Aa syndrome, ASD, ID, Helsmoortel-van der Aa syndrome
Genetic Category
Rare Single Gene Mutation, Syndromic, Functional
Chromosome Band
20q13.13
Associated Disorders
EPS, ADHD, ID, ASD, DD/NDD
Relevance to Autism

Recurrent mutations in the ADNP gene have been identified in multiple individuals with ASD as described below. Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases in two reports by O'Roak and colleagues in 2012 (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; the probability of detecting eight or more de novo truncating events in ADNP was given as P=2.65 x 10-18 in this report (PMID 24531329). Furthermore, the frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led Helsmoortel and colleagues to conclude that ADNP mutations resulted in an autism syndrome. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in De Rubeis et al., 2014 identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

Molecular Function

Potential transcription factor that may mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation. In brain, expression is stronger in the cerebellum and cortex regions.

Reports related to ADNP (42 Reports)
# Type Title Author, Year Autism Report Associated Disorders
1 Primary Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. O'Roak BJ , et al. (2012) Yes -
2 Support Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. O'Roak BJ , et al. (2012) Yes -
3 Recent Recommendation A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Helsmoortel C , et al. (2014) No ASD, DD, ID, epilepsy
4 Recent Recommendation The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism. Vandeweyer G , et al. (2014) Yes ID
5 Recent Recommendation The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. Oz S , et al. (2014) No -
6 Recent Recommendation Synaptic, transcriptional and chromatin genes disrupted in autism. De Rubeis S , et al. (2014) Yes -
7 Support Recurrent de novo mutations implicate novel genes underlying simplex autism risk. O'Roak BJ , et al. (2014) Yes -
8 Support Large-scale discovery of novel genetic causes of developmental disorders. Deciphering Developmental Disorders Study (2014) Yes -
9 Recent Recommendation Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies. Malishkevich A , et al. (2015) No -
10 Support The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey-ADNP Mutation. Gozes I , et al. (2015) Yes -
11 Recent Recommendation Low load for disruptive mutations in autism genes and their biased transmission. Iossifov I , et al. (2015) Yes -
12 Support Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Sanders SJ , et al. (2015) Yes -
13 Support Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. D'Gama AM , et al. (2015) Yes -
14 Support Comprehensive molecular testing in patients with high functioning autism spectrum disorder. Alvarez-Mora MI , et al. (2016) Yes -
15 Support Additional data on the clinical phenotype of Helsmoortel-Van der Aa syndrome associated with a novel truncating mutation in ADNP gene. Krajewska-Walasek M , et al. (2016) No ASD, DD, ID
16 Support Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability Lelieveld SH et al. (2016) No -
17 Support Genome-wide characteristics of de novo mutations in autism Yuen RK et al. (2016) Yes -
18 Support De novo genic mutations among a Chinese autism spectrum disorder cohort. Wang T , et al. (2016) Yes -
19 Support Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Trujillano D , et al. (2016) No -
20 Support Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Stessman HA , et al. (2017) Yes -
21 Support Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder C Yuen RK et al. (2017) Yes -
22 Support Further evidence that a blepharophimosis syndrome phenotype is associated with a specific class of mutation in the ADNP gene. Takenouchi T , et al. (2017) No -
23 Support Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of two clinical units and 216 patients. Chrot E , et al. (2017) No -
24 Support Diagnostic exome sequencing of syndromic epilepsy patients in clinical practice. Tumien B , et al. (2017) No Stereotypic behavior, aggressive behavior
25 Support Helsmoortel-Van der Aa Syndrome as emerging clinical diagnosis in intellectually disabled children with autistic traits and ocular involvement. Pascolini G , et al. (2018) No Autistic behavior
26 Recent Recommendation Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP. Van Dijck A , et al. (2018) No ASD or autistic features
27 Support Longitudinal ophthalmic findings in a child with Helsmoortel-Van der Aa Syndrome. Gale MJ , et al. (2018) No DD, ID
28 Support A heterozygous microdeletion of 20q13.13 encompassing ADNP gene in a child with Helsmoortel-van der Aa syndrome. Huynh MT , et al. (2018) No ID, autistic features
29 Support The autism spectrum phenotype in ADNP syndrome. Arnett AB , et al. (2018) No ASD
30 Support Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes. Guo H , et al. (2018) Yes -
31 Support Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder. Du X , et al. (2018) Yes DD/ID
32 Support Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Guo H , et al. (2018) Yes -
33 Support Both rare and common genetic variants contribute to autism in the Faroe Islands. Leblond CS , et al. (2019) Yes -
34 Recent Recommendation Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome. Bend EG , et al. (2019) No -
35 Support Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort. Callaghan DB , et al. (2019) Yes -
36 Support Developmental Phenotype of the Rare Case of DJ Caused by a Unique ADNP Gene De Novo Mutation. Levine J , et al. (2019) Yes ADHD, behavioral problems
37 Support Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population. Monies D , et al. (2019) Yes -
38 Support Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder. Munnich A , et al. (2019) Yes -
39 Support Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes Feliciano P et al. (2019) Yes -
40 Recent Recommendation Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study. Ivashko-Pachima Y , et al. (2019) No -
41 Support Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism Satterstrom FK et al. (2020) Yes -
42 Support Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome Shillington A et al. (2020) No ASD
Rare Variants   (75)
Status Allele Change Residue Change Variant Type Inheritance Pattern Parental Transmission Family Type PubMed ID Author, Year
A>T - stop_gained De novo NA Simplex 28263302 C Yuen RK et al. (2017)
- - copy_number_loss De novo NA Simplex 29899371 Huynh MT , et al. (2018)
c.632T>A p.Leu211Ter stop_gained De novo NA - 27824329 Wang T , et al. (2016)
c.517C>T p.Arg173Ter stop_gained De novo NA - 28708303 Chrot E , et al. (2017)
c.2157C>G p.Tyr719Ter stop_gained De novo NA - 29780943 Gale MJ , et al. (2018)
c.1102C>T p.Gln368Ter stop_gained Unknown - - 30107084 Arnett AB , et al. (2018)
c.2188C>T p.Arg730Ter stop_gained De novo NA - 29286531 Tumien B , et al. (2017)
c.2157C>A p.Tyr719Ter stop_gained De novo NA - 30107084 Arnett AB , et al. (2018)
c.673C>T p.Arg225Ter stop_gained De novo NA - 28191889 Stessman HA , et al. (2017)
c.2188C>T p.Arg730Ter stop_gained De novo NA - 27479843 Lelieveld SH et al. (2016)
c.2213C>G p.Ser738Ter stop_gained De novo NA - 28191889 Stessman HA , et al. (2017)
c.1930C>T p.Arg644Ter stop_gained Unknown - - 24531329 Helsmoortel C , et al. (2014)
- - copy_number_loss Unknown Not maternal Simplex 30675382 Leblond CS , et al. (2019)
c.2157C>G p.Tyr719Ter stop_gained De novo NA - 28407407 Takenouchi T , et al. (2017)
c.1211C>A p.Ser404Ter stop_gained De novo NA - 24531329 Helsmoortel C , et al. (2014)
c.2157C>G p.Tyr719Ter stop_gained De novo NA - 24531329 Helsmoortel C , et al. (2014)
c.2156dup p.Tyr719Ter frameshift_variant De novo NA - 28708303 Chrot E , et al. (2017)
c.517C>T p.Arg173Ter stop_gained De novo NA Simplex 31406558 Munnich A , et al. (2019)
c.2T>C p.Met1? initiator_codon_variant De novo NA Simplex 30555518 Du X , et al. (2018)
c.10C>G p.Leu4Val frameshift_variant Unknown - Unknown 31130284 Monies D , et al. (2019)
c.118C>T p.Gln40Ter stop_gained De novo NA Simplex 25169753 Vandeweyer G , et al. (2014)
c.2288C>T p.Ser763Phe missense_variant Familial Maternal - 27824329 Wang T , et al. (2016)
c.2157C>G p.Tyr719Ter stop_gained De novo NA Simplex 29475819 Pascolini G , et al. (2018)
c.2188C>T p.Arg730Ter stop_gained De novo NA Simplex 29475819 Pascolini G , et al. (2018)
c.1327A>G p.Thr443Ala missense_variant Unknown - - 26845707 Alvarez-Mora MI , et al. (2016)
c.287del p.Val96AlafsTer65 frameshift_variant Unknown - - 30107084 Arnett AB , et al. (2018)
c.3170T>A p.Leu1057Ter stop_gained De novo NA Simplex 28191889 Stessman HA , et al. (2017)
c.1035_1038del p.Ser346Ter frameshift_variant De novo NA - 28263302 C Yuen RK et al. (2017)
c.339del p.Phe114SerfsTer47 frameshift_variant Unknown - - 30107084 Arnett AB , et al. (2018)
c.2287del p.Ser763ProfsTer9 frameshift_variant Unknown - - 30107084 Arnett AB , et al. (2018)
c.3281G>T p.Gly1094Val missense_variant Unknown - Unknown 26637798 D'Gama AM , et al. (2015)
c.2808del p.Tyr936Ter frameshift_variant De novo NA - 24531329 Helsmoortel C , et al. (2014)
c.2261T>G p.Leu754Ter stop_gained De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.190dup p.Thr64AsnfsTer35 frameshift_variant De novo NA - 30107084 Arnett AB , et al. (2018)
c.1553G>A p.Arg518His missense_variant Unknown - Unknown 25363760 De Rubeis S , et al. (2014)
c.1668G>C p.Gln556His missense_variant Unknown - Unknown 25363760 De Rubeis S , et al. (2014)
c.2881G>T p.Asp961Tyr missense_variant Unknown - Unknown 25363760 De Rubeis S , et al. (2014)
c.3170T>A p.Leu1057Ter stop_gained De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.819del p.Lys274AsnfsTer31 frameshift_variant De novo NA - 30107084 Arnett AB , et al. (2018)
c.746A>G p.Tyr249Cys missense_variant De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.1035_1038del p.Ser346Ter frameshift_variant De novo NA Simplex 27525107 Yuen RK et al. (2016)
c.2157del p.Tyr719Ter frameshift_variant De novo NA Simplex 27848944 Trujillano D , et al. (2016)
c.2188C>T p.Arg730Ter stop_gained De novo NA Simplex 27031564 Krajewska-Walasek M , et al. (2016)
c.3047dup p.Ala1017GlyfsTer6 frameshift_variant Familial Maternal - 27824329 Wang T , et al. (2016)
c.537dup p.Val180SerfsTer2 frameshift_variant De novo NA Simplex 31127536 Levine J , et al. (2019)
c.1046_1047del p.Leu349ArgfsTer49 frameshift_variant De novo NA - 30107084 Arnett AB , et al. (2018)
c.2250_2274del p.Val751MetfsTer13 frameshift_variant De novo NA - 30107084 Arnett AB , et al. (2018)
c.2496_2499del p.Asn832LysfsTer81 frameshift_variant De novo NA - 30107084 Arnett AB , et al. (2018)
c.2251_2275del p.Val751MetfsTer13 frameshift_variant De novo NA - 31452935 Feliciano P et al. (2019)
c.1026dup p.Val343CysfsTer56 frameshift_variant De novo NA Simplex 25418537 O'Roak BJ , et al. (2014)
c.2499del p.Val834SerfsTer80 frameshift_variant De novo NA Simplex 31406558 Munnich A , et al. (2019)
c.2491_2494del p.Leu831IlefsTer82 frameshift_variant De novo NA - 28191889 Stessman HA , et al. (2017)
c.3066_3069del p.Asp1022GlufsTer4 frameshift_variant De novo NA - 28191889 Stessman HA , et al. (2017)
c.2496_2499del p.Asn832LysfsTer81 frameshift_variant De novo NA - 32275126 Shillington A et al. (2020)
c.2153_2165del p.Thr718ArgfsTer6 frameshift_variant De novo NA - 24531329 Helsmoortel C , et al. (2014)
c.2491_2494del p.Leu831IlefsTer82 frameshift_variant De novo NA - 24531329 Helsmoortel C , et al. (2014)
c.2496_2499del p.Asn832LysfsTer81 frameshift_variant De novo NA - 24531329 Helsmoortel C , et al. (2014)
c.2250_2274del p.Val751MetfsTer13 frameshift_variant De novo NA Multiplex 30504930 Guo H , et al. (2018)
c.1046_1047del p.Leu349ArgfsTer49 frameshift_variant De novo NA Simplex 26168855 Gozes I , et al. (2015)
c.2287dup p.Ser763PhefsTer3 frameshift_variant De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.642_649del p.Asn214LysfsTer4 frameshift_variant De novo NA Simplex 25363760 De Rubeis S , et al. (2014)
c.1026dup p.Val343CysfsTer56 frameshift_variant De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.2155del p.Tyr719ThrfsTer9 frameshift_variant Unknown Not maternal Simplex 30564305 Guo H , et al. (2018)
c.1222_1223del p.Lys408ValfsTer31 frameshift_variant De novo NA Simplex 22495309 O'Roak BJ , et al. (2012)
c.2318_2319del p.Lys773IlefsTer14 frameshift_variant Unknown - Unknown 25363760 De Rubeis S , et al. (2014)
c.2156_2157insT p.Glu720ArgfsTer15 frameshift_variant De novo NA Simplex 23160955 O'Roak BJ , et al. (2012)
c.2866_2869del p.Glu956LeufsTer35 frameshift_variant De novo NA Simplex 25363760 De Rubeis S , et al. (2014)
c.2798_2799del p.Gly933ValfsTer10 frameshift_variant Unknown - Multiplex 31038196 Callaghan DB , et al. (2019)
c.1222_1223del p.Lys408ValfsTer31 frameshift_variant De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.2424_2427del p.Lys809SerfsTer19 frameshift_variant De novo NA Simplex 31981491 Satterstrom FK et al. (2020)
c.3280_3281insCC p.Gly1094AlafsTer5 frameshift_variant Familial Maternal Simplex 23160955 O'Roak BJ , et al. (2012)
c.2156dup p.Tyr719Ter frameshift_variant De novo NA Simplex 25533962 Deciphering Developmental Disorders Study (2014)
c.1222_1223del p.Lys408ValfsTer31 frameshift_variant De novo NA Simplex 25533962 Deciphering Developmental Disorders Study (2014)
c.2496_2499del p.Asn832LysfsTer81 frameshift_variant De novo NA Simplex 25533962 Deciphering Developmental Disorders Study (2014)
c.2497_2500del p.Lys833SerfsTer80 frameshift_variant De novo NA Simplex 25533962 Deciphering Developmental Disorders Study (2014)
Common Variants  

No common variants reported.

SFARI Gene score
1

High Confidence

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

Score Delta: Score remained at 1S

1

High Confidence

See all Category 1 Genes

We considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.

4/1/2020
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

1/1/2020
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

10/1/2019
1S
icon
1

Score remained at 1

New Scoring Scheme
Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

7/1/2019
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

4/1/2019
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

1/1/2019
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

10/1/2018
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

7/1/2018
1.1 + S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A detailed clinical characterization of 78 individuals with likely disruptive ADNP mutations in Van Dijck et al., 2018 reported that autistic features were present in 93% (64/69) of individuals, with 67% reported to have a clinical diagnosis of ASD.

7/1/2017
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants in ADNP were identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were identified in patients with ASD in Helsmoortel et al., 2014, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ? 0.01, meaning that this gene had a ? 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

4/1/2017
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

Reports Added
[Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.2012] [Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.2012] [A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP.2014] [The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.2014] [Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies.2015] [The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey-ADNP Mutation.2015] [Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.2015] [Low load for disruptive mutations in autism genes and their biased transmission.2015] [Comprehensive molecular testing in patients with high functioning autism spectrum disorder.2016] [Additional data on the clinical phenotype of Helsmoortel-Van der Aa syndrome associated with a novel truncating mutation in ADNP gene.2016] [Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability2016] [Genome-wide characteristics of de novo mutations in autism2016] [De novo genic mutations among a Chinese autism spectrum disorder cohort.2016] [Clinical exome sequencing: results from 2819 samples reflecting 1000 families.2016] [Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.2017] [Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder2017] [Further evidence that a blepharophimosis syndrome phenotype is associated with a specific class of mutation in the ADNP gene.2017]
1/1/2017
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

10/1/2016
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

7/1/2016
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

4/1/2016
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

1/1/2016
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).

7/1/2015
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).

1/1/2015
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).

10/1/2014
1S
icon
1S

Score remained at 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified ADNP as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).

7/1/2014
No data
icon
1S

Increased from No data to 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329)

4/1/2014
No data
icon
1S

Increased from No data to 1S

Description

Two de novo frameshift variants identified in unrelated simplex ASD cases (PMIDs 22495309 and 23160955). An additional seven de novo LoF variants were recently identified in patients with ASD, giving a current total of nine de novo LoF variants in ADNP gene in ASD cases; probability of detecting eight or more de novo truncating events in ADNP given as P=2.65 x 10-18 in this report. The frequency of shared clinical characteristics in ASD cases with LoF variants in ADNP (intellectual disability, facial dysmorphisms) led the authors to conclude that ADNP mutations resulted in an autism syndrome (PMID 24531329)

Krishnan Probability Score

Score 0.61812008096142

Ranking 91/25841 scored genes


[Show Scoring Methodology]
Krishnan and colleagues generated probability scores genome-wide by using a machine learning approach on a human brain-specific gene network. The method was first presented in Nat Neurosci 19, 1454-1462 (2016), and scores for more than 25,000 RefSeq genes can be accessed in column G of supplementary table 3 (see: http://www.nature.com/neuro/journal/v19/n11/extref/nn.4353-S5.xlsx). A searchable browser, with the ability to view networks of associated ASD risk genes, can be found at asd.princeton.edu.
ExAC Score

Score 0.9989040999292

Ranking 1089/18225 scored genes


[Show Scoring Methodology]
The Exome Aggregation Consortium (ExAC) is a summary database of 60,706 exomes that has been widely used to estimate 'constraint' on mutation for individual genes. It was introduced by Lek et al. Nature 536, 285-291 (2016), and the ExAC browser can be found at exac.broadinstitute.org. The pLI score was developed as measure of intolerance to loss-of- function mutation. A pLI > 0.9 is generally viewed as highly constrained, and thus any loss-of- function mutations in autism in such a gene would be more likely to confer risk. For a full list of pLI scores see: ftp://ftp.broadinstitute.org/pub/ExAC_release/release0.3.1/functional_gene_constraint/fordist_cle aned_exac_nonTCGA_z_pli_rec_null_data.txt
Iossifov Probability Score

Score 0.955

Ranking 78/239 scored genes


[Show Scoring Methodology]
Supplementary dataset S2 in the paper by Iossifov et al. (PNAS 112, E5600-E5607 (2015)) lists 239 genes with a probability of at least 0.8 of being associated with autism risk (column I). This probability metric combines the evidence from de novo likely-gene- disrupting and missense mutations and assesses it against the background mutation rate in unaffected individuals from the University of Washington’s Exome Variant Sequence database (evs.gs.washington.edu/EVS/). The list of probability scores can be found here: www.pnas.org/lookup/suppl/doi:10.1073/pnas.1516376112/- /DCSupplemental/pnas.1516376112.sd02.xlsx
Sanders TADA Score

Score 3.2505367123925E-5

Ranking 10/18665 scored genes


[Show Scoring Methodology]
The TADA score ('Transmission and De novo Association') was introduced by He et al. PLoS Genet 9(8):e1003671 (2013), and is a statistic that integrates evidence from both de novo and transmitted mutations. It forms the basis for the claim of 65 individual genes being strongly associated with autism risk at a false discovery rate of 0.1 (Sanders et al. Neuron 87, 1215-1233 (2015)). The calculated TADA score for 18,665 RefSeq genes can be found in column P of Supplementary Table 6 in the Sanders et al. paper (the column headed 'tadaFdrAscSscExomeSscAgpSmallDel'), which represents a combined analysis of exome data and small de novo deletions (see www.cell.com/cms/attachment/2038545319/2052606711/mmc7.xlsx).
Larsen Cumulative Evidence Score

Score 212

Ranking 3/461 scored genes


[Show Scoring Methodology]
Larsen and colleagues generated gene scores based on the sum of evidence for all available ASD-associated variants in a gene, with assessments based on mode of inheritance, effect size, and variant frequency in the general population. The approach was first presented in Mol Autism 7:44 (2016), and scores for 461 genes can be found in column I in supplementary table 4 from that paper.
Interaction Table
Interactor Symbol Interactor Name Interactor Organism Interactor Type Entrez ID Uniprot ID
2-Sep septin 2 Human Protein Binding 4735 Q15019
ADNP activity-dependent neuroprotector homeobox Human DNA Binding 23394 Q9H2P0
APOE apolipoprotein E Mouse Protein Binding 11816 P08226
ARID1A AT rich interactive domain 1A (SWI-like) Human Protein Binding 8289 O14497
CBX1 chromobox homolog 1 Human Protein Binding 10951 P83916
CBX3 chromobox homolog 3 Human Protein Binding 11335 Q13185
CBX5 chromobox homolog 5 Human Protein Binding 23468 P45973
CDC27 cell division cycle 27 Human Protein Binding 996 G3V1C4
CTSC cathepsin C Mouse Protein Binding 13032 P97821
CTSZ cathepsin Z Mouse Protein Binding 64138 Q9WUU7
EB1 Microtubule-associated protein RP/EB family member 1 Human Protein Binding 22919 Q15691
EB2 Microtubule-associated protein RP/EB family member 2 Human Protein Binding 10982 Q15555
EB3 Microtubule-associated protein RP/EB family member 3 Human Protein Binding 22924 Q9UPY8
EBNA1BP2 EBNA1 binding protein 2 Human Protein Binding 10969 H7C2Q8
EMD emerin Human Protein Binding 2010 P50402
H3F3A H3 histone, family 3A Human Protein Binding 3020 P84243
HBB hemoglobin, beta adult major chain Mouse DNA Binding 15129 P02088
HDAC1 histone deacetylase 1 Human Protein Binding 3065 Q13547
HDAC11 histone deacetylase 11 Human Protein Binding 79885 Q96DB2
HDAC7 histone deacetylase 7 Human Protein Binding 51564 Q8WUI4
MAP1LC3B microtubule-associated protein 1 light chain 3 beta Human Protein Binding 81631 Q9GZQ8
MAPRE1 microtubule-associated protein, RP/EB family, member 1 Human Protein Binding 22919 Q15691
Mapre2 microtubule-associated protein, RP/EB family, member 2 Mouse Protein Binding 212307 Q8R001
MAPRE3 microtubule-associated protein, RP/EB family, member 3 Human Protein Binding 22924 Q9UPY8
MTNR1A melatonin receptor 1A Mouse Protein Binding 17773 Q61184
MYC v-myc myelocytomatosis viral oncogene homolog (avian) Human Protein Binding 4609 P01106
MYL2 myosin, light polypeptide 2, regulatory, cardiac, slow Mouse Protein Binding 17906 P51667
NCAPH2 non-SMC condensin II complex, subunit H2 Human Protein Binding 29781 Q6IBW4
NEUROG1 neurogenin 1 Mouse Protein Binding 18014 P70660
NFIA nuclear factor I/A Human Protein Binding 4774 Q12857
PHGDH phosphoglycerate dehydrogenase Human Protein Binding 26227 O43175
POLG2 polymerase (DNA directed), gamma 2, accessory subunit Human Protein Binding NM_007215 E5KS15
QPRT Nicotinate-nucleotide pyrophosphorylase [carboxylating] Human Protein Binding 23475 Q15274
Rbfox1 RNA binding protein, fox-1 homolog (C. elegans) 1 Mouse RNA Binding 268859 Q9JJ43
RRS1 RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) Human Protein Binding 23212 Q15050
SAP18 Sin3A-associated protein, 18kDa Human Protein Binding 10284 O00422
Sfpq splicing factor proline/glutamine-rich Mouse Protein Binding 71514 Q8VIJ6
SIRT7 sirtuin 7 Human Protein Binding 51547 Q9NRC8
Smarca2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 Mouse Protein Binding 67155 Q6DIC0
SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 Human Protein Binding 6597 A7E2E1
SMARCC2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 Human Protein Binding 6601 Q8TAQ2
Srcin1 SRC kinase signaling inhibitor 1 Mouse Protein Binding 56013 Q9QWI6
SUMO2 SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) Human Protein Binding 6613 P61956
TOP3B topoisomerase (DNA) III beta Human Protein Binding 8940 O95985
Tubb2a tubulin, beta 2A class IIA Mouse Protein Binding 22151 Q7TMM9
ZNF524 Zinc finger protein 524 Human Protein Binding 147807 Q96C55
ZNF581 zinc finger protein 581 Human Protein Binding 51545 Q9P0T4
ZSCAN20 zinc finger and SCAN domain containing 20 Human Protein Binding 7579 P17040
Submit New Gene

Report an Error

SFARI Gene Update

We are pleased to announce some changes to the ongoing curation of the data in SFARI Gene. In the context of a continued effort to develop the human gene module and its manually curated list of autism risk genes, we are modifying other aspects of the site to focus on the information that is of greatest interest to the research community. The version of SFARI Gene that has been developed until now will be frozen and will remain available as “SFARI Gene Archive”. Please see the announcement for more details.
Close